Loading
AC
American Cannabis Company, Inc. Stock: price and insider trades · United States
American Cannabis Company, Inc.: what insiders have been doing
American Cannabis Company, Inc., classified in the Food & Agriculture sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). American Cannabis Company, Inc. has had no insider filing for more than a year; the last one goes back to 29 August 2023.
Over the whole record (from 2021), the tally stands at no purchases and 13 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Village Farms International, Inc. and Orkla ASA. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
27
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€88,566
13 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$2.5M
Gross profitUS$1M42% margin
EBITDA-US$3.3M-133% margin
Net income-US$3.7M-248.5% margin
Valuation
Beta-0.57
Balance sheet & cash
Market capUS$74.3k
Total debtUS$1.2M
Free Cash FlowUS$3.9k
Profitability & ownership
ROE-927.3%
ROA-50.0%
% insiders0.0%
% institutions0.0%
Last declaration on 29 August 2023
Declarations27 total
1,500,000 shares@ US$0.0285.6% of flowCommonSEC:0001903596-23-000685:0
500,000 shares@ US$0.0283.3% of flowCommon StockSEC:0001903596-23-000687:0
17,250,000 shares@ €0.018596.5% of flowCommon StockSEC:0001903596-23-000686:0
10,000,000 shares@ €0.018580.7% of flowCommon StockSEC:0001903596-23-000684:0
1,000,000 shares@ US$0.02100.0% of flowCommon StockSEC:0001903596-23-000037:0
250,000 shares@ US$0.0214.4% of flowCommonSEC:0001903596-23-000039:0
100,000 shares@ US$0.0216.7% of flowCommon StockSEC:0001903596-23-000036:0
500,000 shares@ US$0.02100.0% of flowCommon StockSEC:0001903596-23-000041:0
25,000 shares@ US$0.0533.3% of flowCommonSEC:0001721868-22-000102:0
25,000 shares@ US$0.053.6% of flowCommon StockSEC:0001721868-22-000104:0
50,000 shares@ US$0.0566.7% of flowCommonSEC:0001721868-22-000066:0
50,000 shares@ US$0.059100.0% of flowCommon StockSEC:0001721868-22-000063:0
50,000 shares@ US$0.057.2% of flowCommon StockSEC:0001721868-22-000064:0
50,000 shares@ US$0.059100.0% of flowCommonSEC:0001721868-22-000062:0
50,000 shares@ US$0.05100.0% of flowCommon StockSEC:0001721868-22-000068:0
20,000 shares@ US$0.105.8% of flowCommon StockSEC:0001721868-21-000825:0
25,000 shares@ US$0.107.1% of flowCommon StockSEC:0001721868-21-000800:0
47,200 shares@ US$0.1013.4% of flowCommon StockSEC:0001721868-21-000779:0
33,891 shares@ US$0.109.6% of flowCommon StockSEC:0001721868-21-000769:0
50,000 shares@ US$0.10314.5% of flowCommon StockSEC:0001721868-21-000763:0
100,000 shares@ US$0.108927.7% of flowCommon StockSEC:0001721868-21-000501:0
100,000 shares@ US$0.098625.0% of flowCommon StockSEC:0001721868-21-000505:0
175,000 shares@ US$0.106147.3% of flowCommon StockSEC:0001721868-21-000499:0
20,635 shares@ US$0.1810.0% of flowCommon StockSEC:0001721868-21-000339:0
10,300 shares@ US$0.195.2% of flowCommon StockSEC:0001721868-21-000329:0
25 of 27 declarations
About American Cannabis Company, Inc.
American Cannabis Company, Inc. is a U.S.-based microcap focused on ancillary services and solutions for the regulated cannabis industry in the United States. The company is headquartered in Colorado Springs, Colorado, and is incorporated in Delaware. It trades under the ticker AMMJ on the OTC Markets venue rather than on NYSE or NASDAQ, which makes it a lower-liquidity, higher-risk profile for investors comparing it with mainstream exchange-listed equities. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm))
The company’s origins date back to 2001, when it was formed as Naturewell, Inc. Its current identity was established through a major corporate reset in 2014: following a reverse merger and a divestiture of the legacy business, the company adopted the name American Cannabis Company, Inc. and refocused on the legal cannabis ecosystem. This history matters because it clarifies the business model: the company is not a cannabis cultivator or retailer, but a B2B service provider built around consulting, facility design, and ancillary products. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm))
Read moreShow less
American Cannabis Company’s core business lines are advisory and consulting services for licensed operators and applicants seeking cannabis licenses, along with the design of cannabis-specific facilities and the sale of ancillary products used in the industry. The company also describes a strategic partnership framework that gives it access to both exclusive and non-exclusive products commonly used by cannabis businesses. In investment terms, this is a “picks and shovels” model, which aims to monetize industry growth without taking on the direct operating risks of cultivation, inventory, or retail execution. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm))
From a competitive standpoint, the company operates in a fragmented niche that includes specialist consultants, equipment suppliers, and local service providers. Its differentiation likely comes from sector expertise, regulatory familiarity, and end-to-end support for operators navigating licensing and compliance requirements. The trade-off is scale: as a small company, it has limited brand power, financial resources, and market penetration versus larger multi-state cannabis operators or broader industrial service providers. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000172186820000167/f2sacc10k033020.htm))
Recent developments have centered on corporate governance rather than major commercial expansion. A Form 8-K filed on May 8, 2026 states that Joe Cleghorn stepped down as CEO, remained Chairman of the Advisory Board, and that James Woodend was appointed CEO and Chairman of the Board, effective immediately. For investors, this leadership change is meaningful because it may indicate a new operating cadence or strategic direction. Public disclosures available as of now emphasize management transition more than any material new product launch or major revenue catalyst. ([sec.gov](https://www.sec.gov/Archives/edgar/data/945617/000190359626000195/ammj_8k.htm))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
